Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen Swanson is active.

Publication


Featured researches published by Stephen Swanson.


Chemistry: A European Journal | 2015

A Mild and Regioselective Route to Functionalized Quinazolines

Tracy M. M. Maiden; Stephen Swanson; Panayiotis A. Procopiou; Joseph P. A. Harrity

A Rh-catalyzed ortho-amidation cyclocondensation sequence gave a range of 4-aminoquinazolines in high yield. The method features a remarkably mild C(sp(2) )H activation step and can be exploited to rapidly access compounds with established biological activity.


Organic Letters | 2016

Synthesis of Functionalized Pyridines via a Regioselective Oxazoline Promoted C–H Amidation Reaction

Tracy M. M. Maiden; Stephen Swanson; Panayiotis A. Procopiou; Joseph P. A. Harrity

The first Rh-catalyzed C-H amidation of pyridines is reported. The incorporation of a substituent at the C2 position both is crucial to the success of this transformation and provides considerable scope for further elaboration of the resulting products. Among these compounds, 2-chloropyridines allow access to a selection of intermediates including a versatile azaquinazoline scaffold.


Organic Letters | 2015

2-Iodoisatogens: Versatile Intermediates for the Synthesis of Nitrogen Heterocycles

Elvis J. M. Maduli; Steven J. Edeson; Stephen Swanson; Panayiotis A. Procopiou; Joseph P. A. Harrity

A Cu-promoted cyclization of 2-nitrophenyl iodoacetylenes provides a direct route to a range of 2-iodoisatogens. These compounds represent useful intermediates for the late-stage elaboration of the C-I bond to furnish isatins and a range of alternative heterocyclic products.


Drug Discovery Today | 2013

A practical drug discovery project at the undergraduate level.

M. Jonathan Fray; Simon J. F. Macdonald; Ian Robert Baldwin; Nicholas Paul Barton; Jack A. Brown; Ian B. Campbell; Ian Churcher; Diane Mary Coe; Anthony William James Cooper; Andrew P. Craven; Gail Fisher; Graham G. A. Inglis; Henry A. Kelly; John Liddle; Aoife C. Maxwell; Vipulkumar Kantibhai Patel; Stephen Swanson; Natalie Wellaway

In this article, we describe a practical drug discovery project for third-year undergraduates. No previous knowledge of medicinal chemistry is assumed. Initial lecture workshops cover the basic principles; then students, in teams, seek to improve the profile of a weakly potent, insoluble phosphatidylinositide 3-kinase delta (PI3Kδ) inhibitor (1) through compound array design, molecular modelling, screening data analysis and the synthesis of target compounds in the laboratory. The project benefits from significant industrial support, including lectures, student mentoring and consumables. The aim is to make the learning experience as close as possible to real-life industrial situations. In total, 48 target compounds were prepared, the best of which (5b, 5j, 6b and 6ap) improved the potency and aqueous solubility of the lead compound (1) by 100-1000 fold and ≥tenfold, respectively.


Archive | 2003

Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis

Richard Martyn Arrow Therapeutics Ltd Angell; Ian Robert Baldwin; Paul Bamborough; Nigel Marc GlaxoSmithKline Deboeck; Timothy Longstaff; Stephen Swanson


Archive | 2006

Pyrrolopyrimidine derivatives as SYK inhibitors

Rachael Ann Stevenage Ancliff; Francis Louis Atkinson; Michael David GlaxoSmithKl Barker; Philip Charles Box; Carla Daniel; Paul Martin Gore; Stephen Barry Guntrip; Masaichi Hasegawa; Graham George Adam Inglis; Kazuya Kano; Yasushi Miyazaki; Vipulkumar Kantibhai Patel; Timothy John Ritchie; Stephen Swanson; Ann Louise Walker; Christopher Roland Wellaway; Michael D. Woodrow


Archive | 2005

Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors

Paul Bamborough; Sebastien Andre Campos; Vipulkumar Kantibhai Patel; Stephen Swanson; Ann Louise Walker


Archive | 2003

Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors

Richard Martyn Angell; Paul Bamborough; Ian Robert Baldwin; Anne-Marie Li-Kwai-Cheung; Timothy Longstaff; Suzanne Joy Merrick; Kathryn Jane Smith; Stephen Swanson; Ann Louise Walker


Archive | 2005

P38 kinase inhibitors

Michael David Barker; Julie Nicole Hamblin; Katherine Louise Jones; Vipulkumar Kantibhai Patel; Stephen Swanson; Ann Louise Walker


Archive | 2004

Biphenyl carboxylic amide p38 kinase inhibitors

Nicola Mary Aston; Paul Bamborough; Katherine Louise Jones; Vipulkumar Kantibhai Patel; Stephen Swanson; Ann Louise Walker

Collaboration


Dive into the Stephen Swanson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge